SPINK5, the Defective Gene in Netherton Syndrome, Encodes Multiple LEKTI Isoforms Derived from Alternative Pre-mRNA Processing-Reference-Cited by-同舟云学术

SPINK5, the Defective Gene in Netherton Syndrome, Encodes Multiple LEKTI Isoforms Derived from Alternative Pre-mRNA Processing

Published:2006-02 Issue:2 Volume:126 Page:315-324
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Tartaglia-Polcini Alessandro,Bonnart Chrystelle,Micheloni Alessia,Cianfarani Francesca,Andrè Alessandra,Zambruno Giovanna,Hovnanian Alain,D'Alessio Marina

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference32 articles.

1. Purification and partial amino acid sequence of proteins from human epidermal keratinocyte conditioned medium;Ahmed;J Protein Chem,2001

2. Transcription termination and 3′ processing: the end is in site!;Birnstiel;Cell,1985

3. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome;Bitoun;Hum Mol Genet,2003

4. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome;Chavanas;Nat Genet,2000

5. Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping;Chavanas;Am J Hum Genet,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher Expression of Lympho-epithelial Kazal-type-Related Inhibitor-1 Fragments and Decreased Desquamation in the Lesional Skin of Nummular Eczema;Acta Dermato-Venereologica;2024-03-29

2. Severe Hypernatremia as Presentation of Netherton Syndrome;Global Medical Genetics;2023-11-22

3. Outcomes of Systemic Treatment in Children and Adults With Netherton Syndrome: A Systematic Review;Frontiers in Immunology;2022-03-30

4. Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases;Frontiers in Medicine;2022-03-04

5. Advances in understanding of Netherton syndrome and therapeutic implications;Expert Opinion on Orphan Drugs;2020-11-01